Literature DB >> 25100826

Prevalence and correlates of smoking and cessation-related behavior among survivors of ten cancers: findings from a nationwide survey nine years after diagnosis.

J Lee Westmaas1, Kassandra I Alcaraz2, Carla J Berg3, Kevin D Stein2.   

Abstract

BACKGROUND: Smoking is detrimental to recovery and survival from cancer, but many cancer survivors continue to smoke. Information is lacking on smoking patterns of survivors many years after diagnosis and correlates of smoking status and patterns, likelihood of quitting, and intentions to quit.
METHODS: Cross-sectional analyses were conducted among survivors of 10 cancers recruited by stratified random sampling from cancer registries in a nationwide, longitudinal, quality-of-life study (n = 2,938).
RESULTS: Approximately 9 years after diagnosis, 9.3% of all survivors were current (past 30-day) smokers. Smoking prevalence was highest among survivors of bladder (17.2%), lung (14.9%), and ovarian (11.6%) cancers. Most current smokers (83%) smoked daily, averaging 14.7 cigarettes per day (cpd). Forty percent of daily smokers smoked more than 15 cpd. Nondaily smokers smoked a mean of 10.9 days in the last 30 days and averaged 5.7 cpd on smoking days. Current smoking was associated with younger age, lower education and income, and greater alcohol consumption. Quitting after diagnosis was associated with having a smoking-related cancer. Roughly, a third of current smokers intended to quit, 40% within the next month. The odds of intending to quit were lower if survivors were married, older, or smoked more.
CONCLUSIONS: This population-based study indicated that smoking can persist long after initial diagnosis and at high levels and identified characteristics associated with quitting and intentions to quit. IMPACT: Findings can be used to identify survivors most at risk for continued smoking and to inform tailoring of cessation treatments for survivors. ©2014 American Association for Cancer Research.

Entities:  

Mesh:

Year:  2014        PMID: 25100826     DOI: 10.1158/1055-9965.EPI-14-0046

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  33 in total

1.  Lifestyles of cancer survivors attending an inpatient educational program-a cross-sectional study.

Authors:  Gunhild M Gjerset; Jon H Loge; Sævar B Gudbergsson; Asta Bye; S D Fosså; Line M Oldervoll; Cecilie E Kiserud; Wendy Demark-Wahnefried; Lene Thorsen
Journal:  Support Care Cancer       Date:  2015-09-14       Impact factor: 3.603

2.  AACR Cancer Progress Report 2015.

Authors:  José Baselga; Nina Bhardwaj; Lewis C Cantley; Ronald DeMatteo; Raymond N DuBois; Margaret Foti; Susan M Gapstur; William C Hahn; Lee J Helman; Roy A Jensen; Electra D Paskett; Theodore S Lawrence; Stuart G Lutzker; Eva Szabo
Journal:  Clin Cancer Res       Date:  2015-10-01       Impact factor: 12.531

3.  Smoking status and symptom burden in surgical head and neck cancer patients.

Authors:  Katherine R Sterba; Elizabeth Garrett-Mayer; Matthew J Carpenter; Janet A Tooze; Jeanne L Hatcher; Christopher Sullivan; Lee Anne Tetrick; Graham W Warren; Terrence A Day; Anthony J Alberg; Kathryn E Weaver
Journal:  Laryngoscope       Date:  2016-07-09       Impact factor: 3.325

4.  Dual cigarette and e-cigarette use in cancer survivors: an analysis using Population Assessment of Tobacco Health (PATH) data.

Authors:  Yael R Symes; Kurt M Ribisl; Marcella H Boynton; J Lee Westmaas; Deborah K Mayer; Shelley D Golden
Journal:  J Cancer Surviv       Date:  2019-01-24       Impact factor: 4.442

5.  Smoking cessation attitudes and practices among cancer survivors - United States, 2015.

Authors:  M Shayne Gallaway; Rebecca Glover-Kudon; Behnoosh Momin; Mary Puckett; Natasha Buchanan Lunsford; Kathleen R Ragan; Elizabeth A Rohan; Stephen Babb
Journal:  J Cancer Surviv       Date:  2019-01-05       Impact factor: 4.442

6.  A Qualitative Study of Smoking-Related Causal Attributions and Risk Perceptions in Cervical Cancer Survivors.

Authors:  Gabriella E Puleo; Tia N Borger; Devin Montgomery; Jessica N Rivera Rivera; Jessica L Burris
Journal:  Psychooncology       Date:  2019-11-26       Impact factor: 3.894

7.  Integrating tobacco treatment into cancer care: Study protocol for a randomized controlled comparative effectiveness trial.

Authors:  Elyse R Park; Jamie S Ostroff; Giselle K Perez; Kelly A Hyland; Nancy A Rigotti; Sarah Borderud; Susan Regan; Alona Muzikansky; Emily R Friedman; Douglas E Levy; Susan Holland; Justin Eusebio; Lisa Peterson; Julia Rabin; Jacob Miller-Sobel; Irina Gonzalez; Laura Malloy; Maureen O'Brien; Suhana de León-Sanchez; C Will Whitlock
Journal:  Contemp Clin Trials       Date:  2016-07-19       Impact factor: 2.226

8.  Smoking relapse-prevention intervention for cancer patients: Study design and baseline data from the surviving SmokeFree randomized controlled trial.

Authors:  Diana B Díaz; Thomas H Brandon; Steven K Sutton; Lauren R Meltzer; Hannah J Hoehn; Cathy D Meade; Paul B Jacobsen; Judith C McCaffrey; Eric B Haura; Hui-Yi Lin; Vani N Simmons
Journal:  Contemp Clin Trials       Date:  2016-07-25       Impact factor: 2.226

9.  It's never too late: Smoking cessation after stereotactic body radiation therapy for non-small cell lung carcinoma improves overall survival.

Authors:  Michael C Roach; Sana Rehman; Todd A DeWees; Christopher D Abraham; Jeffrey D Bradley; Cliff G Robinson
Journal:  Pract Radiat Oncol       Date:  2015-09-18

Review 10.  Impact of Gene-Environment Interactions on Cancer Development.

Authors:  Ariane Mbemi; Sunali Khanna; Sylvianne Njiki; Clement G Yedjou; Paul B Tchounwou
Journal:  Int J Environ Res Public Health       Date:  2020-11-03       Impact factor: 3.390

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.